NAMS
NewAmsterdam Pharma Company N.V. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website newamsterdampharma.com
- Employees(FY) 22
- ISIN NL00150012L7
Performance
-0.09%
1W
+4.76%
1M
+5.78%
3M
+113.63%
6M
+95.08%
YTD
+58.13%
1Y
Profile
NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company, develops oral and non-statin medicines for patients at high risk of cardiovascular disease. Its lead product candidate is obicetrapib, a next generation, oral, and low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in four ongoing Phase 3 and Phase 2b clinical trials as both a monotherapy and a combination therapy with ezetimibe for lowering LDL-C and preventing major adverse cardiovascular events (MACE). NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.
Investment Analysis Report: NAMS
Overview
In this investment analysis report, we will delve into a comprehensive analysis of NAMS, a company operating in the Health Technology sector within the Pharmaceuticals: Major industry. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operating ...
Technical Analysis of NAMS 2024-05-03
Overview:
In analyzing the technical indicators for NAMS stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for informe...
Recent News & Updates
- 2024-05-03 16:01
- 2024-05-03 04:01
- 2024-05-02 08:00
- 2024-05-01 20:00
- 2024-04-09 08:00
- 2024-04-08 20:00
- 2024-04-01 08:00
- 2024-03-31 20:00
- 2024-03-25 08:00
- 2024-03-24 20:00
- 2024-03-13 01:32
- 2024-03-12 08:00
- 2024-03-11 20:00
- 2024-03-01 05:14
- 2024-02-28 08:33
- 2024-02-28 08:00
- 2024-02-27 19:00
- 2024-02-26 08:00
- 2024-02-25 19:00
- 2024-02-13 22:40
- 2024-02-13 16:01
- 2024-02-13 09:40
- 2024-02-13 03:01
- 2024-02-01 16:01
- 2024-02-01 03:01
- 2024-01-08 08:00
- 2024-01-07 19:00
- 2024-01-04 08:00
NewAmsterdam Pharma Announces 2024 Strategic Priorities(GlobeNewswire)
- 2024-01-03 19:00
NewAmsterdam Pharma Announces 2024 Strategic Priorities(globenewswire)
- 2024-01-01 07:03
Page 1 of 2
previousnext